Last reviewed · How we verify

NCT05194436

Wheeze Detection Using Aevice Medical Device

Completed Last updated 4 June 2025
What this trial tests

trial testing AeviceMD in Subject Presenting Wheeze in 35 participants. Completed in 18 July 2024.

Timeline
23 April 2021
Primary endpoint
18 July 2023
18 July 2024

Quick facts

Lead sponsorAevice Health Pte. Ltd.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment35
Start date23 April 2021
Primary completion18 July 2023
Estimated completion18 July 2024
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Aevice Health Pte. Ltd.

Who can join

Adults 3 to 18, any sex, with Subject Presenting Wheeze or COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to determine if Aevice Medical Device can detect wheeze as accurately as a physician through auscultation. The secondary objective is to investigate if Aevice Medical Device can be used for remote auscultation of the lung.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing